BLACK WEEKSLiekovky −15 % · kity −10 % · ostatné −5 %s kódomDoprava po Nemecku zadarmo od 200 €

Táto stránka bola preložená automaticky a môže obsahovať chyby. Ste rodený hovoriaci? Radi privítame vašu spätnú väzbu a opravy.Poslať spätnú väzbu

The Peptide Desk The Peptide Desk
BPC-157 Oral, fotografia produktu
Healing Oral

BPC-157 Oral

Healing Oral

  • Odosielame z Nemecka

Objednávka

Cena za kus - Doprava po Nemecku zadarmo od 200 € počas Black Weeks
  • DHL so sledovaním zásielky
  • Diskrétne balenie

4.6 z 5 na Trustpilote73 hodnotení

V skratke

BPC-157 Oral v číslach

Kľúčové údaje z nášho lexikónu.

Celé heslo v lexikóne
Class
Pentadecapeptidehealing, oral
Use
Oraltablet, 500mcg
Sizes
500 mcg1 size in the shop

What studies show

The source in the lexicon
  1. Stable gastric pentadecapeptide BPC 157 and wound healing (review) (opens in a new tab)

    Seiwerth, Sikiric et al., Frontiers in Pharmacology, 2021

Pre BPC-157 Oral zatiaľ neexistuje laboratórna analýza. Hlasujte za toDajte si to otestovať sami, polovicu zaplatímeVšetky laboratórne analýzy

Znalosti

Všetko o BPC-157 Oral

Podrobné informácie pripravujeme.

Dávkovanie

Načítavajú sa informácie o dávkovaní …

Viac v lexikóne

FAQ

Časté otázky

Zdroje ku každej odpovedi: heslo v lexikóne

Máte ešte otázku?

Napíšte nám, náš tím vám pomôže.

Is the tablet different from the capsule?

Not in terms of the compound. Tablet and capsule both contain BPC-157, only the dosage form differs. There are no comparative data between the two forms and no published human study of either.

Is BPC-157 absorbed by mouth at all?

According to a review by the developer group, BPC-157 is stable in human gastric juice. In rat studies it worked via the drinking water much like when injected. There are no blood measurements after oral dosing. After dosing into muscle 14 to 19 percent reached the blood in rats and 45 to 51 percent in dogs, the half-life was under 30 minutes.

What do the animal studies show for the gut?

In rats with a fistula between colon and skin the colon and skin defects healed faster when BPC-157 was injected or added to the drinking water. In short bowel syndrome the animals given BPC-157 by mouth or by injection started gaining weight again right away. There are also findings on alcohol and painkiller damage to the stomach and oesophagus.

Are there studies in humans?

Very few. A systematic review up to June 2026 found three studies with 30 people in total: dosing into the knee, into the bladder and a small safety study into a vein. All without a control group, none with a tablet. The registry also lists a phase 1 tablet study from 2015 and a gummy study completed in 2025, both without published results.

Which trials are running right now?

As of 26 October 2026 no trial with BPC-157 is recruiting. A phase 1 trial with 30 planned participants after shoulder surgery has been announced, where BPC-157 is injected under the skin, with the start planned for January 2027. No tablet trial is currently running.

Which side effects are known?

No treatment-related side effects occurred in the three small human studies, but the certainty is very low. One review found no clinical safety data and names risks from unregulated manufacturing and contamination. There are no data of its own on the tablet.

Súvisiace

Súvisiace produkty